CurrentRheuma
Get Weekly

Topic · page 30 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,161–1,200 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Rheumatology (Oxford)

    Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

    Cohort study

  2. Arthritis Res Ther

    Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry

    Cohort study

  3. Clin Exp Rheumatol

    Assessment of joint inflammation at the wrist of patients with rheumatoid arthritis: thermography findings closely mirror those from ultrasonography

    Cross-sectional study

  4. Arthritis Rheumatol

    The Clinical Impact of Electronic Patient‐Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta‐analysis

    Meta-analysis

  5. Clin Exp Rheumatol

    Challenges and insights in managing difficult-to-treat rheumatoid arthritis: real-world clinical perspectives

    Cross-sectional study

  6. Ann Rheum Dis

    Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)

    Randomized controlled trial

  7. Ann Rheum Dis

    Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)

    Randomized controlled trial

  8. Arthritis Res Ther

    Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry

    Cohort study

  9. Rheumatology (Oxford)

    Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals

    Cohort study

  10. Rheumatology (Oxford)

    Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA

    Cohort study

  11. RMD Open

    Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

    Cohort study

  12. Joint Bone Spine

    The universal presence of poor prognostic factors based on EULAR recommendations: A real-world study in 1164 Chinese RA patients

    Cross-sectional study

  13. Clin Exp Rheumatol

    Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry

    Cohort study

  14. Clin Exp Rheumatol

    STEp-down approach in MEthotrexate use for the Treatment of Rheumatoid Arthritis (STEMETRA): a pilot study demonstrating efficacy and safety of short-term, high dose methotrexate

    Research article

  15. Clin Exp Rheumatol

    Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ

    Mechanistic study

  16. Rheumatology (Oxford)

    Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan

    Cross-sectional study

  17. Arthritis Care Res (Hoboken)

    Patient Perceptions of Rheumatoid Arthritis Blood Work: A Cross‐Sectional Survey in the ArthritisPower Registry

    Cross-sectional study

  18. Clin Exp Rheumatol

    Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies

    Cohort study

  19. Rheumatology (Oxford)

    Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up

    Cohort study

  20. Ann Rheum Dis

    Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

    Randomized controlled trial

  21. Lancet Rheumatol

    Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study

    Randomized controlled trial

  22. RMD Open

    Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study

    Cohort study

  23. Arthritis Res Ther

    A prospective study of the association between serum klotho and mortality among adults with rheumatoid arthritis in the USA

    Cohort study

  24. Ann Intern Med

    The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis: Individual Patient Data From Five Randomized Trials

    Meta-analysis

  25. Rheumatology (Oxford)

    Transcriptomic network analysis reveals key drivers of response to anti-TNF biologics in patients with rheumatoid arthritis

    Mechanistic study

  26. Semin Arthritis Rheum

    Gene-respiratory disease interactions for rheumatoid arthritis risk

    Case-control study

  27. Semin Arthritis Rheum

    Disentangling heterogeneity in contemporary undifferentiated arthritis – A large cohort study using latent class analysis

    Cohort study

  28. RMD Open

    Relative importance of inflammation and cardiorespiratory fitness for all-cause mortality risk in persons with rheumatoid arthritis: the population-based Trøndelag Health Study

    Cohort study

  29. Clin Exp Rheumatol

    Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study

    Cohort study

  30. Semin Arthritis Rheum

    Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic review

    Meta-analysis

  31. Rheumatology (Oxford)

    Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

    Cohort study

  32. Ann Rheum Dis

    Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

    Secondary analysis

  33. RMD Open

    The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis

    Randomized controlled trial

  34. RMD Open

    Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis

    Meta-analysis

  35. Arthritis Rheumatol

    Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling

    Mechanistic study

  36. Arthritis Rheumatol

    Rheumatoid Arthritis–Specific Autoimmunity in the Lung Before and at the Onset of Disease

    Mechanistic study

  37. Arthritis Care Res (Hoboken)

    Sex Differences in Pain and Quantitative Sensory Testing in Patients With Rheumatoid Arthritis

    Secondary analysis

  38. RMD Open

    Are cleaning activities a source of exposure to crystalline silica in women with rheumatoid arthritis? A case–control study

    Research article

  39. RMD Open

    To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals

    Cross-sectional study

  40. Rheumatology (Oxford)

    Proteomics analyses of human plasma reveal triosephosphate isomerase as a potential blood marker of methotrexate resistance in rheumatoid arthritis

    Cross-sectional study

All 1,564 Briefs in ExploreShowing Briefs 1,161–1,200 of 1,564, newest first